Evvy, a precision-medicine platform for women's health, has raised $40 million in Series B funding led by Catalio Capital Management, with a broad syndicate of femtech-focused investors joining the round.
The Bank of Japan convenes its two-day policy meeting on September 17, with economists near-unanimous in expecting a 25 basis-point rate hike to 1.25%, as attention shifts to the pace of subsequent tightening.
The US500 benchmark index rose 0.59% intraday on September 17, a tentative rebound following the prior session's sharp selloff, even as the index remains down 1.24% over the past month amid persistent rate uncertainty.
Global equity markets extended their decline as the Dow Jones Industrial Average dropped 614 points and the 10-year Treasury yield climbed to its highest level since 2007, with traders bracing for continued Federal Reserve tightening.
Digital lending platform Fibe has received SEBI approval for a Rs 750 crore IPO, joining a wave of Indian fintech companies moving toward public listings as investor appetite for the sector shows renewed strength.
The National Stock Exchange of India's long-awaited Rs 22,562 crore IPO opened for subscription on September 17, priced at Rs 1,700 to Rs 1,785 per share, in an offer-for-sale expected to reshape India's unlisted share market.
Veridion, a European AI-driven company-data platform, has raised $20 million in Series A funding led by Hoxton Ventures, extending investor interest in AI infrastructure serving enterprise data and intelligence use cases.
Liquid Compute, a NYC-based startup building a marketplace platform for trading AI infrastructure, has raised $15 million in seed funding co-led by FirstMark and Chemistry, addressing the growing challenge of GPU capacity allocation.
Stuut, an AI platform that automates accounts-receivable work for businesses, has raised $67.6 million in funding according to a recent SEC filing, taking its total equity funding to date past $103 million.
Retham Technologies, a Wauwatosa, Wisconsin-based clinical diagnostics company, has raised a new seed funding round to advance its platform for platelet-related testing, addressing a persistently underserved corner of laboratory medicine.